UNH Stock 2026: Crash to Recovery — Entry at $265
UnitedHealth Group went from $409 to $234 in one of the most brutal selloffs in large-cap healthcare history. A DOJ investigation. A CEO departure. A sector-wide panic. The stock shed 40% in months.
Then, in 30 days, it ripped 35% back to $368. The chart now shows RSI at 87.4 — the most overbought reading since its 2021 peak.
So which is it: genuine recovery or a dead-cat bounce? The answer is probably both — which means the trade is not buying the rip. The trade is waiting for the pullback.
Chart Pattern: V-Bottom Recovery (Overbought)
V-bottoms are powerful but dangerous to chase. The setup here is a violent short-squeeze from panic lows — institutions buying aggressively while short-sellers exit. UNH has ripped straight through its 50-day MA ($289) and 200-day MA ($314) without pausing.
$410 ─── 52-week high (full recovery target, long-term)
$380 ─── Resistance 1
$368 ─── Current price ● (RSI 87.4 — extreme overbought)
$340 ─── ═══════ BUY ZONE (wait here) ═══════
$314 ─── 200-day MA
$289 ─── 50-day MA
$300 ─── Stop loss level
$234 ─── Panic low (52-week bottom)
UNH Stock Price Levels: Support and Entry Zones
| Level | Price | What It Means |
|---|---|---|
| Full recovery | $409.70 | 52-week high — long-term target |
| Resistance 1 | $380 | First meaningful ceiling |
| Current price | $368 | Overbought — do not chase |
| Buy zone | $320–340 | Wait for the pullback to 200-MA area |
| Stop loss | $300 | Below this = bull thesis broken |
SLB Stock Technical Analysis 2026
RSI 87.4 is not a buy signal. It's a warning. Statistically, RSI above 85 on weekly charts precedes 10–20% corrections in 70% of cases. The MACD is bullish (explaining the momentum), but momentum and sustainability are different things.
Both the 50-day and 200-day MAs are pointing down — the long-term trend is still technically bearish. UNH is trading above those averages, but they haven't turned up yet.
The team's read: the panic low at $234 is likely the bottom. But the current price ($368) is not the entry. The entry is the pullback.
The Business Is Intact
UNH generates $25+ billion in annual operating cash flow. With 26 analyst Buy ratings and a $384 consensus target, the institutional view is clear: the DOJ investigation risk is manageable and the core managed-care business is not broken.
Q1 2026 results landed in-line with estimates. The company raised its full-year guidance. CEO Andrew Witty's leadership transition is being managed with continuity. The fundamental case for owning UNH at the right price is strong.
UNH Stock Buy Zone: Where to Enter
Do not buy at $368.
The optimal entry is $320–340 — the 200-day MA convergence zone. A pullback of 8–10% from current levels would get the stock there. At RSI 87, a pullback is not a question of if — it's when.
At $330: stop at $300 ($30 risk), target $384 ($54 reward) = nearly 2:1. That's a trade worth making.
If UNH somehow doesn't pull back and runs straight to $380, another setup will form at that level. Missing a 3% move to get a 2:1 entry is a good trade-off.
UNH Stock Price Target and Stop Loss
- Buy zone: $320–340 (wait for the dip)
- Target: $384 consensus / $409 full recovery
- Stop: $300
- R/R from $330: ~2:1
UNH Stock Risks 2026
The DOJ investigation is ongoing. If new evidence of systematic fraud surfaces, UNH re-tests $234. Political risk in healthcare (Medicare Advantage rate cuts) is structural. RSI 87 means the stock is priced for perfection right now.
UNH Stock 2026: Recovery or Trap?
UNH is a buy — at the right level. Set an alert at $330, be patient, and let the overbought reading resolve. The business is intact. The trade exists. The timing is not today.